Cardarine (GW-501516)
Active Substance: Cardarine
Description
Cardarine (GW-501516), also known as Endurobol, is a synthetic chemical that was developed to address metabolic diseases like obesity, diabetes, and cardiovascular issues. It is a peroxisome proliferator-activated receptor-delta (PPARδ) agonist, not a SARM.
Side Effects and Benefits
Benefits:
-
Increased Endurance: By promoting the use of fat for energy instead of carbohydrates, Cardarine can significantly enhance physical endurance. This allows for longer and more intense workouts.
-
Fat Loss: It is believed to mimic the metabolic effects of exercise, potentially leading to fat loss even without a strict diet or intense physical activity.
-
Improved Lipid Profile: Early research suggested that it could help regulate blood lipid levels, such as cholesterol and triglycerides, which could be beneficial for those with dyslipidemia.
Side Effects:
-
Cancer Risk: The most critical side effect is the potential for rapid and widespread cancer growth. Animal studies led to the discontinuation of human clinical trials because they showed a high incidence of tumors in various organs, including the liver, thyroid, tongue, and stomach.
-
Unknown Long-Term Human Effects: Since human trials were halted, the long-term effects of Cardarine on people are not known.
Pros and Cons
Pros:
-
Potential for significant increases in endurance and fat loss.
-
Does not act as a steroid or SARM, so it does not directly disrupt hormonal balance in the same way.
Cons:
-
High Cancer Risk: The documented risk of cancer in animal studies is a major safety concern.
-
Banned Substance: It is prohibited by major anti-doping agencies like the World Anti-Doping Agency (WADA) and is not approved for human consumption.
-
Lack of Human Data: There is no long-term human data to confirm its safety or effectiveness.
Dosage and Frequency
There is no medically approved dosage for Cardarine. Anecdotal dosages seen on unregulated markets typically range from 10mg to 20mg per day.
Half-Life and Detection Time
-
Half-Life: The half-life is approximately 24 hours, making a once-daily dosage sufficient.
-
Detection Time: While the compound itself is metabolized relatively quickly, its metabolites can be detected in urine for up to 40 days or longer. Hair follicle tests can detect it for up to six months.
Sterogenic, Progestogenic, and Prolactin Effects
Cardarine is a PPARδ agonist, and it does not interact with sex hormone receptors. Therefore, it does not have sterogenic, progestogenic, or prolactin effects. It does not mimic or alter natural sex hormone levels.
Anabolic-Androgenic Ratio
Cardarine does not have an anabolic-androgenic ratio. This ratio is used to measure the effects of anabolic-androgenic steroids (AAS). Since Cardarine is not an AAS and does not affect androgen receptors, this ratio is not applicable.
Pharmacological Properties
Half Life
1 days
Active Dose
100%
Detection
5.00 days
Concentration
10 mg/cap
Anabolic/Androgenic Profile
Usage Effectiveness
Activity Profile
Estrogenic
None
Progestanic
None
Water Retention
None
Aromatization
No
Benefits
Dosage Recommendations
Beginner
10-20 mg/week
Intermediate
20-30 mg/week
Advanced
30-40 mg/week
Evidence-based planning resources
Dive deeper into Cardarine (GW-501516) cycle design, stacking options, and harm-reduction checklists available inside Anabolic Planner.
- Cardarine (GW-501516) compound database overviewCompare Cardarine (GW-501516) with other sarm agents in the structured compound index.
- Cardarine (GW-501516) stack and cycle templatesReview evidence-based cycle outlines, dose progressions, and PCT pairings that incorporate Cardarine (GW-501516).
- Harm-reduction guide for Cardarine (GW-501516)Refresh safety monitoring, lab work, and countermeasure strategies tailored for Cardarine (GW-501516) protocols.
Peer-reviewed reference material
Validate mechanisms, contraindications, and regulatory guidance for Cardarine (GW-501516) with trusted clinical databases.
- Cardarine clinical research on PubMedSearch peer-reviewed human and veterinary studies discussing efficacy, endocrine impact, and contraindications.
- Cardarine pharmacology via Drug Information PortalReview mechanisms, synonyms, regulatory status, and toxicology summaries from the U.S. National Library of Medicine.
Side Effects
Safety Information
Liver Toxicity
Low
Kidney Toxicity
Low
Cardiovascular Risk
Low
Disclaimer: This information is for educational purposes only. Always consult with a qualified healthcare professional before using any compounds.